Lisa Shea Shares Key Takeaways from NORD Summit 2025
Lisa Shea, Director, Global Patient Advocacy and Engagement at Johnson & Johnson, shared on LinkedIn:
”In-person connections with advocacy leaders and partners bring stories to life, spark collaboration, and deepen our understanding of patient priorities—so our work reflects patient needs.
I just returned from this year’s NORD Summit, where the theme, “From Voices to Breakthroughs,” truly resonated with me—especially given my role in advocacy to elevate the patient voice and ensure it informs drug development and healthcare decisions.
Key Session Takeaways:
- Integrate Mental Health: Mental health is physical health; essential to outcomes and helps reduce isolation for patients and caregivers.
- Demonstrate Value for Access: Accelerated approvals need meaningful payer endpoints, proactive payer engagement, and robust patient support.
- Make Science Personal: Authentic storytelling and empathetic leadership foster trust and compassion. Embedding patient stories throughout product launch can make a lasting impact.
I was thrilled to present two abstracts that captured qualitative research on the lived experiences of HDFN and FNAIT pregnancies, highlighting fear, uncertainty and the burden of self-advocacy for individuals faced with alloimmune disease in pregnancy.
My colleague, Zia Choudhry, MD, PhD, MCS, MBA presented on patient-partnered research to shape educational resources in wAIHA.
We were joined by strong advocacy partners – Maternal Alloimmunization Foundation and wAIHA Warriors – grateful to these communities who continue to support and inspire others.”
Stay updated with Hemostasis Today.
-
Nov 3, 2025, 08:23The 1st Participant in A New CHECK-NIRS Clinical Study is Enrolled!
-
Nov 3, 2025, 08:15Bert van Meurs Shares the New Late-breaking Results from the iMODERN Trial
-
Nov 3, 2025, 07:10Lisa Shea Shares Key Takeaways from NORD Summit 2025
-
Nov 3, 2025, 06:49Darshan Doshi on Results of iMODERN and ILIAS ANOCA Studies Presented at TCT 2025
-
Nov 2, 2025, 14:172019 ESC/EAS Guidelines for the Management of Dyslipidaemias Discussion with Lale Tokgözoğlu and Jeanine Roeters van Lennep
-
Nov 3, 2025, 09:13Claudio Carrubba on How Timing Truly Matters in Trauma Embolization
-
Nov 3, 2025, 08:46Rachel Lamerton and Colleagues on Activation of Platelets in Flow Cytometry
-
Nov 3, 2025, 04:56Nirupama Ramadas and Erica Sparkenbaugh on Thromboinflammation in SCD
-
Nov 2, 2025, 14:21Claude Franceschi: I Advise You to Understand the Hemodynamic Pathophysiology of Venous Diseases Rather than Blindly Applying Ablation Techniques or Venous Stent Placement
-
Nov 2, 2025, 14:15Krishna Aragam: Why are (DCM) and Heart Failure About Twice as Common in Individuals of Self-Identified Black Race?
-
Oct 29, 2025, 07:31The Use of Artificial Intelligence to Improve Detection of Acute Incidental Pulmonary Emboli - JTH
-
Oct 29, 2025, 07:05Shrinidhi Nathany: AI in Diagnostic Medicine
-
Oct 28, 2025, 07:02Aya Berman: AI Model for Predicting Bacteremia
-
Oct 28, 2025, 06:55The New Era of Genomics, AI and Cell Therapy in Hematology and Infectious Diseases
-
Oct 28, 2025, 06:49Lukas Gaats: Researchers Are Building Reproductive Organoids
-
Nov 3, 2025, 09:24Stephen Cornelissen: It’s Not Just About Emergencies — It’s About Everyday Care, Chronic Conditions and Hope
-
Nov 3, 2025, 06:57Maria Elisa Mancuso Reflects on 2025 Annual Congress of the Italian Association of Hemophilia Centres
-
Nov 3, 2025, 05:46Chandra Viswanathan: When Blood Safety Fails, We All Bleed - A Call for Reform and Responsibility
-
Nov 2, 2025, 14:17Anamaria B: Your Mother Still Runs Part of Your DNA
-
Nov 2, 2025, 10:57Paul Bolaji on Launching The First Centralised Nigerian National Stroke Registry